ACE and heart failure: The successive application after ACE inhibitors and beta‐blockers may be due to historical reasons related to later large pivotal studies (RALES [Randomized Aldactone Evaluation Study], 199988; EMPHASIS‐HF [Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure], 201189) rather than lower efficacy in HF.